Search

Your search keyword '"Pedersen, Mikkel W."' showing total 217 results

Search Constraints

Start Over You searched for: Author "Pedersen, Mikkel W." Remove constraint Author: "Pedersen, Mikkel W."
217 results on '"Pedersen, Mikkel W."'

Search Results

2. Population genomics of the Viking world

4. Postglacial viability and colonization in North America’s ice-free corridor

7. Abstract CT274: Individualized APC targeting VB10.NEO cancer vaccines induce broad neoepitope-specific CD8 T cell responses in patients with advanced or metastatic solid tumors: interim results from a phase 1/2a trial

10. Data from Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer

11. Supplementary methods from Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms

15. Supplementary Figures 1-7 from Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms

17. Data from Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms

19. Supplementary Figure S1 from Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer

21. Supplementary Table S2 from Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer

22. Supplementary Figure Legend from Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer

23. Supplementary Figures S1-8 from Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity

24. Supplementary Tables S1-2 from Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity

25. Author Correction: Population genomics of the Viking world

26. An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

28. Ancient Human Genomes and Environmental DNA from the Cement Attaching 2,000-Year-Old Head Lice Nits

29. Chiquihuite Cave and America's Hidden Limestone Industries:A Reply to Chatters et al.

30. Ancient Human Genomes and Environmental DNA from the Cement Attaching 2,000-Year-Old Head Lice Nits

31. Chiquihuite Cave and America’s Hidden Limestone Industries: A Reply to Chatters et al.

33. Abstract 1797: Preclinical characterization of Sym024, a novel anti-CD73 antibody

34. Lake Sedimentary DNA Research on Past Terrestrial and Aquatic Biodiversity: Overview and Recommendations

35. Lake Sedimentary DNA Research on Past Terrestrial and Aquatic Biodiversity:Overview and Recommendations

36. Deep neural networks identify signaling mechanisms of ErbB-family drug resistance from a continuous cell morphology space

37. Lake Sedimentary DNA Research on Past Terrestrial and Aquatic Biodiversity: Overview and Recommendations

38. Population genomics of the Viking world:[incl. correction]

41. Ancient Human Genomes and Environmental DNA from the Cement Attaching 2,000-Year-Old Head Lice Nits.

43. Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype

45. Shotgun Environmental DNA, Pollen, and Macrofossil Analysis of Lateglacial Lake Sediments From Southern Sweden

48. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform

49. Chiquihuite Cave and America’s Hidden Limestone Industries: A Reply to Chatters et al.

50. Archaeal community changes in Lateglacial lake sediments : Evidence from ancient DNA

Catalog

Books, media, physical & digital resources